324 related articles for article (PubMed ID: 30804658)
1. Changes in tear biomarker levels in keratoconus after corneal collagen crosslinking.
Recalde JI; Duran JA; Rodriguez-Agirretxe I; Soria J; Sanchez-Tena MA; Pereiro X; Suarez T; Acera A
Mol Vis; 2019; 25():12-21. PubMed ID: 30804658
[TBL] [Abstract][Full Text] [Related]
2. Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays.
Benitez-Del-Castillo JM; Soria J; Acera A; Muñoz AM; Rodríguez S; Suárez T
Mol Vis; 2021; 27():243-261. PubMed ID: 34012227
[TBL] [Abstract][Full Text] [Related]
3. Tear function and ocular surface changes following corneal collagen cross-linking treatment in keratoconus patients: 18-month results.
Uysal BS; Akcay E; Kilicarslan A; Mutlu M; Hondur G; Kosekahya P; Cagil N
Int Ophthalmol; 2020 Jan; 40(1):169-177. PubMed ID: 31440935
[TBL] [Abstract][Full Text] [Related]
4. Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes.
Kolozsvári BL; Berta A; Petrovski G; Miháltz K; Gogolák P; Rajnavölgyi E; Hassan Z; Széles P; Fodor M
PLoS One; 2013; 8(10):e76333. PubMed ID: 24124547
[TBL] [Abstract][Full Text] [Related]
5. Tear Function and Ocular Surface Alterations After Accelerated Corneal Collagen Cross-Linking in Progressive Keratoconus.
Kalkan Akçay E; Kilicarslan A; Uysal BS; Hondur G; Kosekahya P; Altinkaynak H; Cagil N
Eye Contact Lens; 2017 Sep; 43(5):302-307. PubMed ID: 27171133
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.
Mutlu M; Sarac O; Cağıl N; Avcıoğlu G
Int Ophthalmol; 2020 Jan; 40(1):51-57. PubMed ID: 31363950
[TBL] [Abstract][Full Text] [Related]
7. Ocular Surface Disease Parameters After Collagen Cross-Linking for Keratoconus.
Recalde JI; Acera A; Rodríguez-Agirretxe I; Sánchez-Tena MA; San-Cristóbal J; Durán JA
Cornea; 2017 Feb; 36(2):148-152. PubMed ID: 28060060
[TBL] [Abstract][Full Text] [Related]
8. Tear Martix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Post-Lasik Ectasia.
Elmohamady MN; Abdelghaffar W; Salem TI
Int Ophthalmol; 2019 Mar; 39(3):631-637. PubMed ID: 29478225
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of galectin-1 and galectin-3 as prospective biomarkers in keratoconus.
Andrade FEC; Covre JL; Ramos L; Hazarbassanov RM; Santos MSD; Campos M; Gomes JÁP; Gil CD
Br J Ophthalmol; 2018 May; 102(5):700-707. PubMed ID: 29439091
[TBL] [Abstract][Full Text] [Related]
10. Tear Mediators in Corneal Ectatic Disorders.
Pásztor D; Kolozsvári BL; Csutak A; Berta A; Hassan Z; Ujhelyi B; Gogolák P; Fodor M
PLoS One; 2016; 11(4):e0153186. PubMed ID: 27074131
[TBL] [Abstract][Full Text] [Related]
11. Two-year topographic and densitometric outcomes of accelerated (45 mW/cm
Huang J; Shen Y; Jian W; Xu H; Li M; Zhao J; Zhou X; Liao H
BMC Ophthalmol; 2018 Dec; 18(1):337. PubMed ID: 30587181
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized contralateral eye study of accelerated and conventional corneal cross-linking in pediatric keratoconus.
Eissa SA; Yassin A
Int Ophthalmol; 2019 May; 39(5):971-979. PubMed ID: 29564806
[TBL] [Abstract][Full Text] [Related]
13. Signs and Symptoms of Dry Eye in Keratoconus Patients: A Pilot Study.
Carracedo G; Recchioni A; Alejandre-Alba N; Martin-Gil A; Crooke A; Morote IJ; Pintor J
Curr Eye Res; 2015; 40(11):1088-94. PubMed ID: 25495191
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A.
Shetty R; Ghosh A; Lim RR; Subramani M; Mihir K; Reshma AR; Ranganath A; Nagaraj S; Nuijts RM; Beuerman R; Shetty R; Das D; Chaurasia SS; Sinha-Roy A; Ghosh A
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):738-50. PubMed ID: 25648341
[TBL] [Abstract][Full Text] [Related]
15. Corneal surface wettability and tear film stability before and after scleral lens wear.
Serramito M; Privado-Aroco A; Batres L; Carracedo G G
Cont Lens Anterior Eye; 2019 Oct; 42(5):520-525. PubMed ID: 30967331
[TBL] [Abstract][Full Text] [Related]
16. Changes in corneal sensation and ocular surface in patients with asymmetrical keratoconus.
Cho KJ; Mok JW; Choi MY; Kim JY; Joo CK
Cornea; 2013 Feb; 32(2):205-10. PubMed ID: 23146931
[TBL] [Abstract][Full Text] [Related]
17. Effect of corneal collagen cross-linking on corneal innervation, corneal sensitivity, and tear function of patients with keratoconus.
Kontadakis GA; Kymionis GD; Kankariya VP; Pallikaris AI
Ophthalmology; 2013 May; 120(5):917-22. PubMed ID: 23337554
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
[TBL] [Abstract][Full Text] [Related]
19. Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up.
Bikbova G; Kazakbaeva G; Bikbov M; Usubov E
Int Ophthalmol; 2018 Jun; 38(3):1285-1293. PubMed ID: 28620706
[TBL] [Abstract][Full Text] [Related]
20. Accelerated versus standard corneal collagen cross-linking in pediatric keratoconus patients: 24 months follow-up results.
Sarac O; Caglayan M; Uysal BS; Uzel AGT; Tanriverdi B; Cagil N
Cont Lens Anterior Eye; 2018 Oct; 41(5):442-447. PubMed ID: 29910023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
